CEO of Avadel Pharmaceuticals Plc (30-Year Financial, Insider Trades) Greg J Divis (insider trades) bought 19,000 shares of AVDL on 11/15/2019 at an average price of $5.13 a share. The total cost of this purchase was $97,470.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company developing and commercializing pharmaceutical products. The company's products include Bloxiverz, Vazculep, Akovaz, Karbinal ER, AcipHex Sprinkle, Cefaclor and Flexichamber. Avadel Pharmaceuticals PLC has a market cap of $180.110 million; its shares were traded at around $4.81 with and P/S ratio of 2.62. GuruFocus has detected 2 severe warning signs with Avadel Pharmaceuticals PLC. .
CEO Recent Trades:
- CEO Greg J Divis bought 19,000 shares of AVDL stock on 11/15/2019 at the average price of $5.13. The price of the stock has decreased by 6.24% since.
Directors and Officers Recent Trades:
- Director Eric J Ende bought 10,000 shares of AVDL stock on 11/15/2019 at the average price of $4.98. The price of the stock has decreased by 3.41% since.
For the complete insider trading history of AVDL, click here
.